Back | Next |
home / stock / itci / itci message board
Subject | By | Source | When |
---|---|---|---|
Carl Icahn took stake today | Biggeoff | investorshub | 12/24/2019 4:33:20 PM |
Christmas Eve run! | crudeoil24 | investorshub | 12/24/2019 2:34:44 PM |
50+ today | europtiger | investorshub | 12/24/2019 1:17:38 PM |
* * $ITCI Video Chart 12-23-2019 * * | ClayTrader | investorshub | 12/23/2019 9:35:47 PM |
ALL IN=$$$$ | TheFinalCD | investorshub | 12/23/2019 8:54:45 PM |
I was in and out here for a | Cosa | investorshub | 12/23/2019 8:17:17 PM |
$ITCI Banked here | BoilerRoom | investorshub | 12/23/2019 6:21:39 PM |
Analyzer suggested a buy when this was $8 | grich1 | investorshub | 12/23/2019 6:06:15 PM |
This is precisely why my trading days begin | davidsson10 | investorshub | 12/23/2019 5:09:29 PM |
$40 | TheFinalCD | investorshub | 12/23/2019 4:26:46 PM |
This will run hard | europtiger | investorshub | 12/23/2019 4:05:37 PM |
$ITCI is a great $$$$$ opportunity. | crudeoil24 | investorshub | 12/23/2019 2:34:06 PM |
We believe CAPLYTA provides healthcare providers a new, | crudeoil24 | investorshub | 12/23/2019 2:26:43 PM |
May have some noise now | UKdude | investorshub | 12/23/2019 2:13:40 PM |
Quiet** | jRu | investorshub | 12/16/2019 9:19:27 PM |
Pretty quit here for a spec play... | jRu | investorshub | 12/16/2019 9:18:04 PM |
* * $ITCI Video Chart 07-23-2019 * * | ClayTrader | investorshub | 07/23/2019 8:13:25 PM |
* * $ITCI Video Chart 07-08-2019 * * | ClayTrader | investorshub | 07/08/2019 8:06:31 PM |
Nice Call No Revenues Losing 141 Million Dollars | Stockexpertpro | investorshub | 12/18/2018 6:17:50 PM |
https://seekingalpha.com/news/3291224-intra-cellular-gets-good-news-fda-related- | Avispa | investorshub | 08/23/2017 12:55:51 PM |
News, Short Squeeze, Breakout and More Instantly...
Intra-Cellular Therapies Inc. Company Name:
ITCI Stock Symbol:
NASDAQ Market:
Intra-Cellular Therapies Inc. Website:
CAPLYTA Q1 2024 net product sales were $144.8 million , compared to $94.7 million for the same period in 2023 , representing a 53% increase CAPLYTA’s strong prescription uptake continues: Q1 2024 CAPLYTA total prescripti...
Aterian Inc. (ATER) is expected to report for Q1 2024 Dorman Products Inc. (DORM) is expected to report $0.82 for Q1 2024 Hillman Solutions Corp. (HLMN) is expected to report $0.08 for Q1 2024 Wake Forest Bancshares, Inc. (WAKE) is expected to report for quarter end 2024-03-31 Inn...
NEW YORK, April 30, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (NASDAQ:ITCI), a biopharmaceutical company focused on the developme...